Health Canada
www.hc-sc.gc.ca
Home
> Consumer Product Safety
> Pesticides & Pest Management
> Protecting Your Health & the Environment
> Public Registry
> Product Information > Disclaimer > Incident Reports " >Incident Type
Incident Report
Subform I: General Information
1. Report Type.
New incident report
Incident Report Number: 2015-3404
2. Registrant Information.
Registrant Reference Number: 2015-19
Registrant Name (Full Legal Name no abbreviations): BASF Canada
Address: 100 Milverton
City: Mississauga
Prov / State: ON
Country: Canada
Postal Code: L5R4H1
3. Select the appropriate subform(s) for the incident.
Scientific Study
4. Date registrant was first informed of the incident.
5. Location of incident.
6. Date incident was first observed.
Product Description
7. a) Provide the active ingredient and, if available, the registration number and product name (include all tank mixes). If the product is not registered provide a submission number.
Active(s)
PMRA Registration No. 21995
PMRA Submission No.
EPA Registration No.
Product Name: Pendimethalin
7. b) Type of formulation.
Application Information
8. Product was applied?
Unknown
9. Application Rate.
10. Site pesticide was applied to (select all that apply).
11. Provide any additional information regarding application (how it was applied, amount applied, the size of the area treated etc).
To be determined by Registrant
12. In your opinion, was the product used according to the label instructions?
Unknown
Subform VII: Scientific Study
1. Study Reference
Title Chromosome Aberration study CHO V79 cells in vitro
Date 24-JUL-13
2. a) Is an extension needed to translate the document?
No
3. Type of incident identified in the study
New health or environmental hazard
4. Describe the incident identified in the study (e.g. study demonstrates an increased risk to non-Hodgkin's Lymphoma after exposure to pesticide X)
Tox test new metabolite BAS455 pendimethalin
5. a) Was the study discontinued before completion?
No
5. b) Provide the reason for discontinuation
6. If the study is ongoing, what is the expected completion date?
For Registrant use only
7. Provide supplemental information here
Follow-up to studies on new metabolite